You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

Browse

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Beyond LDL lowering: the role of dyslipidaemia and inflammation

The British Journal of Diabetes & Vascular Disease

Journal indexing and metrics

Journal Homepage Submission guidelines

Restricted access

Editorial

First published online May, 2003

Beyond LDL lowering: the role of dyslipidaemia and inflammation

Volume 3, Issue 3

https://doi.org/10.1177/14746514030030030101

Abstract

Get full access to this article

View all access options for this article.

References

Elkeles RS , Diamond JR , Poulter C. et al. The SENDCAP Study Group. Cardiovascular outcomes in type 2 diabetes . Diabetes Care 1998;21: 641-8.

Diabetes Atherosclerosis Intervention Study Investigators. Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet 2001;357:905-10.

Browse journal

Current issue OnlineFirst All issues